Bookmark With:

ELAN (ELN) Stock Quote

Stock Web

Detailed Quote for ELAN (ELN)

close 52 Week Information

52 Week High

July 02,2009

Close: 8.59

52 Week Low

October 29,2009

Close: 4.61

Today

Last Price
7.44

Change $
0.19

Change %
2.62%

Tick

Bid
6.50

Bid Size
200

Ask
7.51

Ask Size
1000

Open
7.23

High
7.45

Low
7.23

Prev Close
7.25

Last Trade
3/11/10

Volume
0

52 Wk Hi
8.59

52 Wk Low
4.61

Market Cap
4.34 b

Ex-Div Date
N/A

Div Rate
0.00

Yield
0.00

Shares
583,901,211

EPS (TTM)
-0.35

PE Ratio
N/A

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for ELAN (ELN)

Sector News | Topic News

News for ELN

Wed, Mar 03, 2010

5:54 PM

Elan to Present at the Cowen and Company Healthcare Conference - Business Wire

Sun, Feb 28, 2010

7:00 PM

Neuroimaging Technique Supports Reduction in Amyloid-Beta in Brains of Patients Suffering from Alzheimer's Disease Treated with Bapineuzumab - Business Wire

Thu, Feb 25, 2010

7:03 PM

Elan Announces Filing of Annual Report on Form 20-F for Year Ended December 31, 2009 - Business Wire

Wed, Feb 10, 2010

2:00 AM

Elan Reports Fourth Quarter and Full-Year 2009 Financial Results - Business Wire

Thu, Feb 04, 2010

12:46 PM

Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research - CNW

12:45 PM

Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research - PR Newswire

Wed, Jan 27, 2010

4:51 PM

Elan Announces Webcast of Fourth Quarter and Full Year 2009 Financial Results - Business Wire

Mon, Jan 25, 2010

2:00 AM

Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets - Business Wire

Mon, Jan 11, 2010

8:00 AM

World-Renowned Yogi Baron Baptiste Unveils New Program to Help People with Multiple Sclerosis - Business Wire

Tue, Jan 05, 2010

5:33 PM

Elan to Present at the 2010 J.P. Morgan Healthcare Conference - Business Wire

Thu, Dec 17, 2009

12:54 PM

Aeolus Pharmaceuticals' AEOL 11207 Subject of Research Grant from Michael J. Fox Foundation - Business Wire

Tue, Dec 15, 2009

2:00 AM

Elan and Transition Therapeutics Announce Modifications to ELND005 Phase II Clinical Trials in Alzheimer's Disease - Business Wire

Mon, Dec 14, 2009

2:00 AM

Elan Drug Technologies Announces First Japanese Approval of Product Using Its NanoCrystal(R) Technology - Business Wire

Mon, Nov 30, 2009

2:00 PM

The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments - PR Newswire

Thu, Nov 12, 2009

7:03 AM

XOM, ELN, X, WY, FO and GCA Free Research report on BenchmarkJournal.com - Marketwire

Tue, Nov 03, 2009

5:21 AM

Complimentary Sector & Company Analysis on CBE, ELN, WFC, BEN, NCS and LRY from TheFortuneFinancial.com - Marketwire

Tue, Oct 27, 2009

6:51 AM

Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com - GlobeNewswire

Fri, Oct 23, 2009

7:22 AM

Fundamental Analysis on ELN, GME, LPL, ETN, MET and LUK brought to you by AnalystChoice.com - Marketwire

Wed, Oct 14, 2009

6:13 AM

WY, AVB, ELN, KWK, WLT and MAR Receives Analytical Coverage from WallStSense.com - Marketwire

Mon, Oct 05, 2009

6:28 AM

RothmanResearch.com Stock Review for BDN, ELN, GIS, FIS, MDT and KFT - Marketwire

More News for ELN >>

Tags for ELAN

Research stocks or mutual funds related to ELAN by keywords or tags. Find companies that have a similar focus to ELN. The keywords below have been associated to ELN by either user submission or electronic means.

biotech research elan pharmaceutical publication biotech conference pharmaceutical market Commercial Physical And Biological Research (8731) generic pharmaceutical elan products pharmaceutical investment pharmaceutical patents clinical research consulting pharmaceutical research and development pharmaceutical manufacturing company pharmaceutical software pharma manufacturing pharmaceutical clinical research kv pharmaceutical company gmp pharmaceutical elan pharm generic products elan pharmaceuticals pharmaceutical cro American Depository Receipt (ADR) active pharmaceutical ingredients pharmaceutical conferences pfizer top selling products pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine biotech pharmaceutical patent Drugs elan m666 pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference clinical trials conference pharmaceutical manufacturing elan company pharmaceutical formulation company research online elan contract pharmaceutical pharmaceutical consulting pharmaceutical events pharmaceutical industry

Subject	Author	Posted
A smallcap company’s Phase 2 Alzheimer's drug data	debapriya	7/13/2009 8:53 AM EST
Upcoming data of an Alzheimer's drug	debarati	7/13/2009 8:52 AM EST